379 related articles for article (PubMed ID: 35278677)
21. Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022.
Piralla A; Mojoli F; Pellegrinelli L; Ceriotti F; Valzano A; Grasselli G; Gismondo MR; Micheli V; Castelli A; Farina C; Arosio M; Lorini FL; Fanti D; Busni A; Laratta M; Maggi F; Novazzi F; Cabrini L; Callegaro AP; Keim R; Remuzzi G; Cavallero A; Malandrin SMI; Rona R; Giardina F; Ferrari G; Zavaglio F; D'angelo P; Galli C; Bubba L; Binda S; Oggioni M; Uceda Renteria SC; Bono P; Baj A; Ferrante FD; Guarneri D; Tonelli M; Napolitano G; Nava A; Romeo L; Nicolini E; Valaperta R; Varisano L; Mele C; Liguori L; Raggi M; Mongodi S; Pagani M; Severgnini P; Gasberti D; Bonanomi E; Gritti P; Marrazzo F; Giovannini I; Sacchi N; Sagliocco O; Cereda D; Buoro S; Baldanti F; Pariani E
Respir Med Res; 2023 Jun; 83():100990. PubMed ID: 36871459
[TBL] [Abstract][Full Text] [Related]
22. Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas.
Christensen PA; Olsen RJ; Long SW; Snehal R; Davis JJ; Ojeda Saavedra M; Reppond K; Shyer MN; Cambric J; Gadd R; Thakur RM; Batajoo A; Mangham R; Pena S; Trinh T; Kinskey JC; Williams G; Olson R; Gollihar J; Musser JM
Am J Pathol; 2022 Apr; 192(4):642-652. PubMed ID: 35123975
[TBL] [Abstract][Full Text] [Related]
23. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
24. Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in China.
Zeng QL; Lv YJ; Liu XJ; Jiang ZY; Huang S; Li WZ; Yu ZJ
Front Microbiol; 2022; 13():901826. PubMed ID: 35847120
[TBL] [Abstract][Full Text] [Related]
25. Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
Abas AH; Marfuah S; Idroes R; Kusumawaty D; Fatimawali ; Park MN; Siyadatpanah A; Alhumaydhi FA; Mahmud S; Tallei TE; Emran TB; Kim B
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408618
[TBL] [Abstract][Full Text] [Related]
26. Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022.
Stefanelli P; Trentini F; Petrone D; Mammone A; Ambrosio L; Manica M; Guzzetta G; d'Andrea V; Marziano V; Zardini A; Molina Grane' C; Ajelli M; Di Martino A; Riccardo F; Bella A; Sane Schepisi M; Maraglino F; Poletti P; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Merler S; ; ; ;
Euro Surveill; 2022 Nov; 27(45):. PubMed ID: 36367013
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and outcomes of vaccinated and nonvaccinated patients hospitalized in a single Italian hub for COVID-19 during the Delta and Omicron waves in Northern Italy.
Rovida F; Esposito GL; Rissone M; Novelli V; Cutti S; Muzzi A; Rona C; Bertoli E; Daglio M; Piralla A; Paolucci S; Campanini G; Ferrari G; Giardina F; Zavaglio F; Lilleri D; Grugnetti AM; Grugnetti G; Odone A; Marena C; Baldanti F
Int J Infect Dis; 2022 Sep; 122():420-426. PubMed ID: 35750265
[TBL] [Abstract][Full Text] [Related]
28. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
Ferdinands JM; Rao S; Dixon BE; Mitchell PK; DeSilva MB; Irving SA; Lewis N; Natarajan K; Stenehjem E; Grannis SJ; Han J; McEvoy C; Ong TC; Naleway AL; Reese SE; Embi PJ; Dascomb K; Klein NP; Griggs EP; Konatham D; Kharbanda AB; Yang DH; Fadel WF; Grisel N; Goddard K; Patel P; Liao IC; Birch R; Valvi NR; Reynolds S; Arndorfer J; Zerbo O; Dickerson M; Murthy K; Williams J; Bozio CH; Blanton L; Verani JR; Schrag SJ; Dalton AF; Wondimu MH; Link-Gelles R; Azziz-Baumgartner E; Barron MA; Gaglani M; Thompson MG; Fireman B
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):255-263. PubMed ID: 35176007
[TBL] [Abstract][Full Text] [Related]
29. Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.
Esper FP; Adhikari TM; Tu ZJ; Cheng YW; El-Haddad K; Farkas DH; Bosler D; Rhoads D; Procop GW; Ko JS; Jehi L; Li J; Rubin BP
J Infect Dis; 2023 Feb; 227(3):344-352. PubMed ID: 36214810
[TBL] [Abstract][Full Text] [Related]
30. Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.
Pedersen RM; Bang LL; Madsen LW; Sydenham TV; Johansen IS; Jensen TG; Justesen US; Andersen TE
Emerg Infect Dis; 2022 Jun; 28(6):1274-1275. PubMed ID: 35356875
[TBL] [Abstract][Full Text] [Related]
31. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
[TBL] [Abstract][Full Text] [Related]
32. An exploratory study on the propagation of SARS-CoV-2 variants: Omicron is the most predominant variant.
Rathinasamy M; Kandhasamy S
J Med Virol; 2022 Jun; 94(6):2414-2421. PubMed ID: 35112734
[TBL] [Abstract][Full Text] [Related]
33. Booster BNT162b2 COVID-19 Vaccination Increases Neutralizing Antibody Titers Against the SARS-CoV-2 Omicron Variant in Both Young and Elderly Adults.
Um J; Choi YY; Kim G; Kim MK; Lee KS; Sung HK; Kim BC; Lee YK; Jang HC; Bang JH; Chung KH; Oh MD; Park JS; Jeon J
J Korean Med Sci; 2022 Mar; 37(9):e70. PubMed ID: 35257525
[TBL] [Abstract][Full Text] [Related]
34. Paediatric admissions with SARS-CoV-2 during the Delta and Omicron waves: an Australian single-centre retrospective study.
Cheng DR; Schrader S; McMinn A; Crawford NW; Tosif S; Mcnab S; Steer AC
BMJ Paediatr Open; 2023 Mar; 7(1):. PubMed ID: 36882231
[TBL] [Abstract][Full Text] [Related]
35. Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
Novazzi F; Baj A; Genoni A; Focosi D; Maggi F
Emerg Infect Dis; 2022 Jun; 28(6):1301-1302. PubMed ID: 35416767
[TBL] [Abstract][Full Text] [Related]
36. Analysis of SARS-CoV-2 Cases, COVID-19 Outcomes and Vaccinations, during the Different SARS-CoV-2 Variants in Greece.
Malli F; Lampropoulos IC; Perlepe G; Papagiannis D; Gourgoulianis KI
Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679971
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of clinical characteristics of 362 vaccinated or unvaccinated patients infected by novel coronavirus Omicron variant].
Feng Q; Wang Z; Yu H; Shi L; Xu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 May; 34(5):459-464. PubMed ID: 35728844
[TBL] [Abstract][Full Text] [Related]
38. Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.
Parums DV
Med Sci Monit; 2022 Feb; 28():e936199. PubMed ID: 35102132
[TBL] [Abstract][Full Text] [Related]
39. Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong.
Wong JY; Cheung JK; Lin Y; Bond HS; Lau EHY; Ip DKM; Cowling BJ; Wu P
J Infect Dis; 2023 Nov; 228(9):1231-1239. PubMed ID: 37368235
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of CoronaVac in children 3-5 years of age during the SARS-CoV-2 Omicron outbreak in Chile.
Jara A; Undurraga EA; Zubizarreta JR; González C; Acevedo J; Pizarro A; Vergara V; Soto-Marchant M; Gilabert R; Flores JC; Suárez P; Leighton P; Eguiguren P; Ríos JC; Fernandez J; García-Escorza H; Araos R
Nat Med; 2022 Jul; 28(7):1377-1380. PubMed ID: 35605637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
